LEXX Financial Statements

Balance sheet, income statement, cash flow, and dividends for Lexaria Bioscience Corp (LEXX).


$61.82M Market Cap.

As of 11/26/2024 5:00 PM ET (MRY) • Disclaimer

LEXX Market Cap. (MRY)


LEXX Shares Outstanding (MRY)


LEXX Assets (MRY)


Total Assets

$8.87M

Total Liabilities

$1.21M

Total Investments

$55.81K

LEXX Income (MRY)


Revenue

$464.28K

Net Income

-$5.80M

Operating Expense

$6.21M

LEXX Cash Flow (MRY)


CF Operations

-$4.96M

CF Investing

-$188.60K

CF Financing

$10.32M

LEXX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

LEXX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$8,867,789 (187.54%)

$3,083,986 (-60.63%)

$7,833,927 (-40.95%)

$13,266,817 (369.08%)

Assets Current

$7,897,986 (259.04%)

$2,199,772 (-68.47%)

$6,977,516 (-43.92%)

$12,442,940 (546.06%)

Assets Non-Current

$969,803 (9.68%)

$884,214 (3.25%)

$856,411 (3.95%)

$823,877 (-8.69%)

Goodwill & Intangible Assets

$516,676 (11.68%)

$462,625 (-5.29%)

$488,462 (33.96%)

$364,623 (24.87%)

Shareholders Equity

$8,036,400 (164.00%)

$3,044,118 (-61.70%)

$7,948,904 (-40.08%)

$13,265,637 (425.33%)

Property Plant & Equipment Net

$389,552 (-7.60%)

$421,589 (14.58%)

$367,949 (-19.88%)

$459,254 (-24.75%)

Cash & Equivalents

$6,499,885 (380.72%)

$1,352,102 (-76.74%)

$5,813,218 (-46.75%)

$10,917,797 (743.89%)

Accumulated Other Comprehensive Income

-$19,816 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$4,963 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$55,807 (-55.58%)

$125,642 (-63.83%)

$347,335 (-58.35%)

$833,841 (4215.72%)

Investments Current

$55,807 (-55.58%)

$125,642 (-63.83%)

$347,335 (-58.35%)

$833,841 (4215.72%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$38,418 (29.58%)

$29,648 (-74.63%)

Trade & Non-Trade Receivables

$218,052 (24.43%)

$175,245 (-13.15%)

$201,784 (-41.07%)

$342,401 (9.07%)

Trade & Non-Trade Payables

$1,066,409 (344.45%)

$239,941 (58.43%)

$151,449 (43.56%)

$105,496 (-27.56%)

Accumulated Retained Earnings (Deficit)

-$51,558,772 (-12.66%)

-$45,763,427 (-17.05%)

-$39,098,528 (-22.84%)

-$31,829,204 (-14.48%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$137,366 (-16.22%)

$163,967 (228.01%)

$49,988 (-48.63%)

$97,319 (-37.66%)

Debt Current

$28,047 (0.91%)

$27,794 (-34.74%)

$42,587 (-10.02%)

$47,330 (31.33%)

Debt Non-Current

$109,319 (-19.72%)

$136,173 (1739.93%)

$7,401 (-85.19%)

$49,989 (-58.36%)

Total Liabilities

$1,208,738 (199.26%)

$403,908 (100.51%)

$201,437 (-0.90%)

$203,265 (-41.25%)

Liabilities Current

$1,099,419 (310.64%)

$267,735 (37.98%)

$194,036 (26.59%)

$153,276 (-32.15%)

Liabilities Non-Current

$109,319 (-19.72%)

$136,173 (1739.93%)

$7,401 (-85.19%)

$49,989 (-58.36%)

LEXX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$464,278 (105.24%)

$226,208 (-11.43%)

$255,397 (-64.66%)

$722,738 (129.59%)

Cost of Revenue

$4,822 (-84.69%)

$31,500 (-56.15%)

$71,841 (-59.03%)

$175,346 (76.44%)

Selling General & Administrative Expense

$3,852,021 (25.80%)

$3,062,009 (-38.26%)

$4,959,920 (-0.23%)

$4,971,349 (25.00%)

Research & Development Expense

$2,360,565 (-35.62%)

$3,666,721 (98.99%)

$1,842,675 (45.91%)

$1,262,895 (226.27%)

Operating Expenses

$6,212,586 (-7.67%)

$6,728,730 (-1.09%)

$6,802,595 (44.38%)

$4,711,540 (7.96%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$22,000 (134.28%)

Consolidated Income

-$5,808,654 (12.85%)

-$6,664,899 (8.31%)

-$7,269,324 (-80.51%)

-$4,027,006 (-2.36%)

Net Income to Non-Controlling Interests

-$13,309 (-127.94%)

$47,626 (-58.34%)

$114,329 (-28.16%)

$159,142 (5.66%)

Net Income

-$5,795,345 (13.66%)

-$6,712,525 (9.09%)

-$7,383,653 (-76.38%)

-$4,186,148 (-2.49%)

Preferred Dividends Income Statement Impact

$0 (0%)

-$47,626 (58.34%)

-$114,329 (28.16%)

-$159,142 (-5.66%)

Net Income Common Stock

-$5,795,345 (13.05%)

-$6,664,899 (8.31%)

-$7,269,324 (-80.51%)

-$4,027,006 (-2.36%)

Weighted Average Shares

$12,383,974 (87.24%)

$6,614,066 (12.38%)

$5,885,245 (34.02%)

$4,391,446 (58.34%)

Weighted Average Shares Diluted

$12,383,974 (87.24%)

$6,614,066 (12.38%)

$5,885,245 (34.02%)

$4,391,446 (58.34%)

Earning Before Interest & Taxes (EBIT)

-$5,795,345 (13.66%)

-$6,712,525 (9.09%)

-$7,383,653 (-76.38%)

-$4,186,148 (-2.49%)

Gross Profit

$459,456 (135.97%)

$194,708 (6.08%)

$183,556 (-66.47%)

$547,392 (154.11%)

Operating Income

-$5,753,130 (11.95%)

-$6,534,022 (1.28%)

-$6,619,039 (-58.95%)

-$4,164,148 (-0.37%)

LEXX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$188,605 (-11.20%)

-$169,610 (6.11%)

-$180,640 (-193.17%)

$193,880 (822.27%)

Net Cash Flow from Financing

$10,315,207 (548.86%)

$1,589,731 (3664.42%)

-$44,600 (-100.33%)

$13,419,846 (405.60%)

Net Cash Flow from Operations

-$4,959,003 (15.68%)

-$5,881,237 (-20.53%)

-$4,879,339 (-22.30%)

-$3,989,678 (-52.35%)

Net Cash Flow / Change in Cash & Cash Equivalents

$5,147,783 (215.39%)

-$4,461,116 (12.61%)

-$5,104,579 (-153.04%)

$9,624,048 (111781.52%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$273,373 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$43,014 (-27.46%)

-$33,748 (31.40%)

-$49,192 (0%)

$0 (0%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

-$44,600 (33.13%)

-$66,694 (-382.38%)

Issuance (Purchase) of Equity Shares

$10,315,207 (548.86%)

$1,589,731 (0%)

$0 (0%)

$13,486,540 (405.48%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$19,816 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$492,236 (188.90%)

$170,382 (-77.36%)

$752,591 (83.56%)

$410,007 (-64.01%)

Depreciation Amortization & Accretion

$115,428 (-38.99%)

$189,188 (29.13%)

$146,510 (-5.79%)

$155,509 (-0.16%)

LEXX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

99.00% (14.98%)

86.10% (19.75%)

71.90% (-5.02%)

75.70% (10.67%)

Profit Margin

-1248.20% (57.64%)

-2946.40% (-3.52%)

-2846.30% (-410.82%)

-557.20% (55.41%)

EBITDA Margin

-1223.40% (57.58%)

-2883.80% (-1.77%)

-2833.70% (-408.10%)

-557.70% (55.32%)

Return on Average Equity (ROAE)

-81.60% (42.86%)

-142.80% (-97.78%)

-72.20% (-67.13%)

-43.20% (72.22%)

Return on Average Assets (ROAA)

-80.30% (41.60%)

-137.50% (-89.66%)

-72.50% (-71.80%)

-42.20% (70.82%)

Return on Sales (ROS)

-1248.20% (57.94%)

-2967.40% (-2.64%)

-2891.00% (-399.14%)

-579.20% (55.36%)

Return on Invested Capital (ROIC)

-534.20% (27.98%)

-741.70% (-75.47%)

-422.70% (-88.71%)

-224.00% (44.01%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-8.32 (-699.90%)

-1.04 (56.43%)

-2.39 (63.54%)

-6.55 (8.34%)

Price to Sales Ratio (P/S)

104.29 (239.74%)

30.7 (-54.99%)

68.21 (80.48%)

37.79 (-59.15%)

Price to Book Ratio (P/B)

7.69 (175.60%)

2.79 (25.95%)

2.22 (-7.40%)

2.39 (-80.73%)

Debt to Equity Ratio (D/E)

0.15 (12.78%)

0.13 (432.00%)

0.03 (66.67%)

0.01 (-89.05%)

Earnings Per Share (EPS)

-0.47 (53.47%)

-1.01 (18.55%)

-1.24 (-30.53%)

-0.95 (35.37%)

Sales Per Share (SPS)

0.04 (8.82%)

0.03 (-20.93%)

0.04 (-73.94%)

0.17 (44.74%)

Free Cash Flow Per Share (FCFPS)

-0.4 (54.81%)

-0.89 (-6.81%)

-0.84 (7.92%)

-0.91 (3.71%)

Book Value Per Share (BVPS)

0.65 (41.09%)

0.46 (-65.95%)

1.35 (-55.28%)

3.02 (231.61%)

Tangible Assets Book Value Per Share (TABVPS)

0.67 (70.20%)

0.4 (-68.27%)

1.25 (-57.52%)

2.94 (221.44%)

Enterprise Value Over EBIT (EV/EBIT)

-9 (-800.00%)

-1 (0.00%)

-1 (83.33%)

-6 (14.29%)

Enterprise Value Over EBITDA (EV/EBITDA)

-9.42 (-1016.00%)

-0.84 (42.55%)

-1.47 (75.07%)

-5.89 (21.14%)

Asset Turnover

0.06 (36.17%)

0.05 (88.00%)

0.03 (-67.11%)

0.08 (-34.48%)

Current Ratio

7.18 (-12.56%)

8.22 (-77.15%)

35.96 (-55.70%)

81.18 (852.26%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$5,002,017 (15.43%)

-$5,914,985 (-20.02%)

-$4,928,531 (-23.53%)

-$3,989,678 (-52.35%)

Enterprise Value (EV)

$53,501,408 (871.62%)

$5,506,421 (-48.21%)

$10,631,941 (-55.23%)

$23,747,913 (-19.09%)

Earnings Before Tax (EBT)

-$5,795,345 (13.66%)

-$6,712,525 (9.09%)

-$7,383,653 (-76.38%)

-$4,186,148 (-2.49%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$5,679,917 (12.93%)

-$6,523,337 (9.86%)

-$7,237,143 (-79.55%)

-$4,030,639 (-2.59%)

Invested Capital

$889,175 (-23.71%)

$1,165,491 (-16.04%)

$1,388,199 (-28.01%)

$1,928,440 (64.45%)

Working Capital

$6,798,567 (251.89%)

$1,932,037 (-71.52%)

$6,783,480 (-44.80%)

$12,289,664 (622.90%)

Tangible Asset Value

$8,351,113 (218.58%)

$2,621,361 (-64.31%)

$7,345,465 (-43.07%)

$12,902,194 (408.71%)

Market Capitalization

$61,817,902 (627.66%)

$8,495,423 (-51.77%)

$17,614,954 (-44.52%)

$31,748,945 (1.25%)

Average Equity

$7,105,577 (52.19%)

$4,668,869 (-53.62%)

$10,067,168 (8.08%)

$9,314,550 (268.26%)

Average Assets

$7,216,261 (48.85%)

$4,848,020 (-51.68%)

$10,033,094 (5.17%)

$9,540,274 (250.72%)

Invested Capital Average

$1,084,883 (19.87%)

$905,043 (-48.19%)

$1,746,716 (-6.53%)

$1,868,708 (83.05%)

Shares

15,810,205 (95.39%)

8,091,650 (35.97%)

5,950,998 (16.59%)

5,104,332 (70.93%)